Literature DB >> 18220758

Chemical instability determines the biological action of the artemisinins.

F Herwig Jansen1, Shahid A Soomro.   

Abstract

Artemisinin is a sesquiterpene compound of plant origin. It has a low molecular weight, and it contains five oxygen atoms, two in a lactone function, one is part of a seven membered ring system and two forms a peroxide function bridging over the seven-membered ring. It is a highly energetic molecule prone to lose its activity if circumstances permit. Reduction of its lactone function into dihydroartemisinin makes derivatization easy. Esterification and ether formation contribute to stability. Dihydroartemisinin exists preferably in a beta epimeric format but flip-flops with the alpha epimer. Solvation effects play a role. In doing so, open forms are created and they contribute to the instability, both of the peroxide and of the seven-membered ring. Artemisinins constitute a remarkable class of compounds which display instability both biologically and chemically due to the presence of various functional groups. Activity ranges from a wonderful action against a series of parasites, in particular malaria and schistosomiasis, to bacteria, fungi and selected viruses. The latest developments indicate a potential use in adjuvant cancer chemotherapy. The built-in chemical instability, necessary for biological action, causes serious pharmaceutical problems and only a restricted number of derivatives are useful. Problems are accelerated under tropical conditions and the basic active drug dihydroartemisinin cannot be used as such since it is prone to accelerated breakdown into a series of inactive products. The pitfalls of chemical instability and pharmaceutical stability are discussed in relation to the current uses of the drugs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18220758     DOI: 10.2174/092986707782793844

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  7 in total

1.  Comparative oral bioavailability of non-fixed and fixed combinations of artesunate and amodiaquine in healthy Indian male volunteers.

Authors:  Anny Fortin; Roger K Verbeeck; Frans H Jansen
Journal:  Eur J Clin Pharmacol       Date:  2010-10-15       Impact factor: 2.953

2.  Dimeric Artesunate Glycerophosphocholine Conjugate Nano-Assemblies as Slow-Release Antimalarials to Overcome Kelch 13 Mutant Artemisinin Resistance.

Authors:  Xinsong Li; Leann Tilley; Yawei Du; Carlo Giannangelo; Wei He; Gerald J Shami; Wenya Zhou; Tuo Yang; Darren J Creek; Con Dogovski
Journal:  Antimicrob Agents Chemother       Date:  2022-04-13       Impact factor: 5.938

3.  The pharmaceutical death-ride of dihydroartemisinin.

Authors:  Frans Herwig Jansen
Journal:  Malar J       Date:  2010-07-22       Impact factor: 2.979

4.  Preparation of bicyclic 1,2,4-trioxanes from gamma,delta-unsaturated ketones.

Authors:  Armando P Ramirez; Andrew M Thomas; K A Woerpel
Journal:  Org Lett       Date:  2009-02-05       Impact factor: 6.005

5.  Design of novel artemisinin-like derivatives with cytotoxic and anti-angiogenic properties.

Authors:  Shahid Soomro; Tobias Langenberg; Anne Mahringer; V Badireenath Konkimalla; Cindy Horwedel; Pavlo Holenya; Almut Brand; Canan Cetin; Gert Fricker; Mieke Dewerchin; Peter Carmeliet; Edward M Conway; Herwig Jansen; Thomas Efferth
Journal:  J Cell Mol Med       Date:  2010-07-12       Impact factor: 5.310

6.  The Quality of Selected Essential Medicines Sold in Accredited Drug Dispensing Outlets and Pharmacies in Tanzania.

Authors:  Eliangiringa Kaale; Vicky Manyanga; Mhina Chambuso; Jafary Liana; Edmund Rutta; Martha Embrey; Thomas Layloff; Keith Johnson
Journal:  PLoS One       Date:  2016-11-15       Impact factor: 3.240

7.  Efficacy and safety of a fixed dose artesunate-sulphamethoxypyrazine-pyrimethamine compared to artemether-lumefantrine for the treatment of uncomplicated falciparum malaria across Africa: a randomized multi-centre trial.

Authors:  Issaka Sagara; Stephen Rulisa; Wilfred Mbacham; Ishag Adam; Kourane Sissoko; Hamma Maiga; Oumar B Traore; Niawanlou Dara; Yahia T Dicko; Alassane Dicko; Abdoulaye Djimdé; F Herwig Jansen; Ogobara K Doumbo
Journal:  Malar J       Date:  2009-04-14       Impact factor: 2.979

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.